Showing 4,681 - 4,700 results of 4,871 for search 'background composition (method OR methods)', query time: 0.21s Refine Results
  1. 4681

    Final shade and whiteness: impact of various ultra-thin CAD/CAM veneers and tooth-colored resin substrates by Yinghui Wang, Xia Wei, Linjuan Gao, Dingkun Liu, Xing Chen, Liujun Lin, Yu Pan, Hao Yu, Guang Hong, Hui Cheng

    Published 2025-04-01
    “…Abstract Background Achieving optimal color control in chairside CAD/CAM ultra-thin veneers, remains a significant challenge for dental clinicians and technicians. …”
    Get full text
    Article
  2. 4682

    Effects of transcranial alternating current stimulation combined with sertraline on cognitive function in patients with depressive disorder by Li Dan, Xia Zhong, Zhu Wenli, Liang Dandan, Miao Wenwen, Song Chuanfu

    Published 2025-06-01
    “…BackgroundCognitive function is closely related to an individual's quality of life and social functioning, with approximately 20%~35% of patients with depressive disorder experiencing some degree of cognitive impairment even after clinical symptom remission. …”
    Get full text
    Article
  3. 4683

    Staged versus immediate complete revascularization for non-culprit arteries in acute myocardial infarction: a post-hoc analysis of FRAME-AMI by Yongwhan Lim, Jaehyuk Jang, Seung Hun Lee, Joon Ho Ahn, Young Joon Hong, Youngkeun Ahn, Myung Ho Jeong, Chan Joon Kim, Joo-Yong Hahn, Joo Myung Lee, Keun Ho Park, Eun Ho Choo, Sung Gyun Ahn, Joon-Hyung Doh, Sang Yeub Lee, Sang Don Park, Hyun-Jong Lee, Min Gyu Kang, Yun-Kyeong Cho, Chang Wook Nam, Sung Hyun Bu, Min Chul Kim

    Published 2024-12-01
    “…Background and objectivesThe optimal timing for complete revascularization (CR) in patients with acute myocardial infarction (AMI) and multivessel disease (MVD) remain uncertain.MethodsThis post-hoc analysis of the FRAME-AMI trial included AMI patients with MVD (n = 549). …”
    Get full text
    Article
  4. 4684

    Unraveling the Oncogenic Characteristics of the Cytolinker, Plectin, in Esophageal Squamous Cell CarcinomaSummary by Lili Qiao, Yuanyuan Hu, Lei Xu, Guodong Deng, Xiaohong Yu, Wei Zheng, Yanan Yang, Hui Yuan, Wei Jiang, Xiying Yu

    Published 2025-01-01
    “…Background & Aims: Tissue mechanics involved in carcinogenesis by regulating cell morphology and structure, cell-cell, and cell-extracellular matrix (ECM) interactions are not fully understood. …”
    Get full text
    Article
  5. 4685

    Intravenous Administration of sRNA Nanoparticles for Treatment of Osteoporosis in Mice by Xuemeng Mu, Xinyi Du, Huitian Han, Fei Liu, Zhifa Zheng, Jing Hao, Lijin Liu, Su Liu, Ze Wei, Changfa Huang, Annan Liang, Wei Zou, Lina Zhao, Zhihong Wu, Jia Zhang

    Published 2025-06-01
    “…This study explores the potential of LNPs as an effective delivery system to treat osteoporosis. <b>Methods</b>: LNPs were prepared using microfluidic techniques with varying lipid compositions, and characterized in terms of size, zeta potential, and entrapment efficiency (EE%). …”
    Get full text
    Article
  6. 4686
  7. 4687
  8. 4688
  9. 4689
  10. 4690
  11. 4691
  12. 4692

    Prevalence of Variant GTR<sup>I</sup><i>Staphylococcus aureus</i> Isolated from Dairy Cow Milk Samples in the Alpine Grazing System of the Aosta Valley and Its Association with AMR... by Valentina Monistero, Delower Hossain, Sara Fusar Poli, Elizabeth Sampaio de Medeiros, Paola Cremonesi, Bianca Castiglioni, Filippo Biscarini, Hans Ulrich Graber, Giulia Mochettaz, Sandra Ganio, Alessandra Gazzola, Maria Filippa Addis, Claudio Roullet, Antonio Barberio, Silvia Deotto, Lara Biasio, Fernando Ulloa, Davide Galanti, Valerio Bronzo, Paolo Moroni

    Published 2025-03-01
    “…The aim of this study was to provide an overview of <i>S. aureus</i> genotypes associated with antimicrobial resistance (AMR) and virulence profiles in four dairy herds in the Aosta Valley from July 2022 to August 2023. <b>Methods</b>: A total of 468 composite milk samples were collected at three timepoints: T1 (pasture-livestock system), T2 (farm-livestock system), and T3 (pasture-livestock system). …”
    Get full text
    Article
  13. 4693

    Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis by Alexandros A. Polymeris, Masatoshi Koga, Daniel Strbian, Adhiyaman Vedamurthy, Manju Krishnan, Mattia Branca, Thomas Horvath, Martina Goeldlin, Gek Shim, Christoph Gumbinger, Liqun Zhang, Espen Saxhaug Kristoffersen, Philippe Desfontaines, Peter Vanacker, Angelika Alonso, Sven Poli, Ana Paiva Nunes, Nicoletta G. Caracciolo, Markus Kneihsl, Timo Kahles, Daria Giudici, Silja Räty, Marjaana Tiainen, Jesse Dawson, Urs Fischer, for the ELAN Investigators

    Published 2025-05-01
    “…Here, we explored the risks and benefits of this approach. Methods A post-hoc analysis of ELAN (Early versus Late Initiation of Direct Oral Anticoagulants in Post-ischemic Stroke Patients with Atrial Fibrillation) trial data (NCT03148457) was conducted to compare the risk of recurrent ischemic stroke, systemic embolism, major bleeding (extracranial or intracranial hemorrhage [ICH]), and vascular death within 30 days (as a composite and as individual outcomes) in participants treated with and without antiplatelets before DOAC initiation after an AF-associated ischemic stroke. …”
    Get full text
    Article
  14. 4694

    Predicting brain amyloid load with digital and blood-based biomarkers by Weineng Chen, Yu Liao, Xinchong Shi, Fengjuan Su, Haifan Kong, Yingying Fang, Yifan Zheng, Jiayi Zhou, Ganqiang Liu, Xianbo Zhou, Xiaoli Yao, Curtis B. Ashford, Feng Li, Long Yang, Michael F. Bergeron, J. Wesson Ashford, Xiangsong Zhang, Zhong Pei

    Published 2025-07-01
    “…Methods MemTrax, a 2-minute online memory test, was selected as the digital biomarker of cognitive impairment, and blood-based biomarkers (BBMs) including Aβ42, Aβ40, P-tau181, GFAP and NfL were used to estimate AD-related metrics in different groups of elderly individuals (n = 349) for comparison with Aβ PET scans of brain Aβ burden. …”
    Get full text
    Article
  15. 4695

    Role and prognostic value of growth differentiation factor 15 in patient of heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF registry by Tetsuhisa Kitamura, Shungo Hikoso, Takahisa Yamada, Yoshio Yasumura, Akito Nakagawa, Toshihiro Takeda, Hirota Kida, Akihiro Sunaga, Tomoharu Dohi, Katsuki Okada, Daisaku Nakatani, Yasushi Matsumura, Yasushi Sakata, Shunsuke Tamaki, Takaharu Hayashi, Yoshiharu Higuchi, Masaharu Masuda, Mitsutoshi Asai, Toshiaki Mano, Hisakazu Fuji, Daisaku Masuda, Shizuya Yamashita, Masami Sairyo, Yusuke Nakagawa, Haruhiko Abe, Yasunori Ueda, Kunihiko Nagai, Masamichi Yano, Masami Nishino, Jun Tanouchi, Yoh Arita, Shinji Hasegawa, Takamaru Ishizu, Minoru Ichikawa, Yuzuru Takano, Eisai Rin, Tetsuya Watanabe, Shiro Hoshida, Masahiro Izumi, Hiroyoshi Yamamoto, Hiroyasu Kato, Kazuhiro Nakatani, Mayu Nishio, Keiji Hirooka, Takahiro Yoshimura, Akihiro Tani, Yasushi Okumoto, Yasunaka Makino, Katsuomi Iwakura, Yoshiyuki Kijima, Takashi Kitao, Masashi Fujita, Koichiro Harada, Masahiro Kumada, Osamu Nakagawa, Ryo Araki, Takayuki Yamada, Fusako Sera, Kei Nakamoto, Hidetaka Kioka, Tomohito Ohtani, Nobuyuki Ogasawara, Yukinori Shinoda, Koichi Tachibana, Yohei Sotomi, Taiki Sato, Yuji Yasuga, Toshinari Onishi, Kazunori Kashiwase, Ryu Shutta, Masahiro Seo, Yuki Matsuoka, Yasuhiro Akazawa, Daisuke Sakamoto

    Published 2025-01-01
    “…Background Growth differentiation factor 15 (GDF15) is a cytokine responding to oxidative stress and inflammation, and it regulates appetite and energy balance. …”
    Get full text
    Article
  16. 4696

    Patient-reported Outcome Measures and Decision Regret After Prostate-specific Membrane Antigen–targeted Radioguided Surgery for Oligorecurrent Prostate Cancer by Fabian Falkenbach, Giovanni Mazzucato, Zhe Tian, Pierre I. Karakiewicz, Markus Graefen, Thomas Steuber, Derya Tilki, Daniel Koehler, Burkhard Beyer, Pierre Tennstedt, Sophie Knipper, Lars Budäus, Tobias Maurer

    Published 2024-12-01
    “…Data on patient-reported outcome measures (PROMs) are lacking. Methods: A retrospective assessment of validated PROMs (12-item Short Form Health Survey [SF-12], 26-item Expanded Prostate Index Composite, and Decision Regret Scale [DRS]) was performed before and after PSMA-RGS for oligorecurrent PCa. …”
    Get full text
    Article
  17. 4697
  18. 4698
  19. 4699
  20. 4700

    Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome by Wenbo Dai, Guanyu Mu, Jiayi Ren, Sutao Hu, Rongxin Guo, Tian-shu Gu, Jingjin Che, Xianghong Ma, Tong Liu, Xue Wu, Jing-Kun Zhang, Gary Tse, Yajie Wang, Jian-Mei Zhou, Seung-Woon Rha, Kangyin Chen

    Published 2025-07-01
    “…Abstract Background Antiplatelet therapy is pivotal in managing elderly patients with Acute Coronary Syndrome (ACS) following Percutaneous Coronary Intervention (PCI). …”
    Get full text
    Article